Restricted information is readily available on the intense toxicity of methocarbamol. Overdose of methocarbamol is frequently together with liquor or other CNS downers and includes the belowing symptoms: queasiness, sleepiness, blurred vision, hypotension, seizures, and also coma. In post-marketing experience deaths have actually been reported with an overdose of methocarbamol alone or in the existence of other CNS depressants, liquor or psychotropic drugs.
Management of overdose consists of encouraging and also symptomatic treatment. Supportive procedures include upkeep of a sufficient airway, monitoring urinary system result as well as crucial signs, as well as administration of intravenous fluids if necessary. The usefulness of hemodialysis in handling overdose is unknown.
Robaxin Injectable (100 mg/mL) provided in-- 10 mL single dose vials in packages of 25 (NDC 0641-6103-25).
To report SUSPECTED ADVERSE REACTIONS, call West-Ward Pharmaceutical Corp. at 1-877-845-0689 or the FDA at 1-800-FDA-1088 or www. fda. gov/medwatch.
Robaxin Injectable (Methocarbamol Injection, USP) 1, 000 mg/10 mL (100 mg/mL) 10 mL Single Dose Vial NDC 0641-6103-01.
Robaxin Injectable (Methocarbamol Injection, USP) 1, 000 mg/10 mL (100 mg/mL) 25 x 10 mL Single Dose Vials NDC 0641-6103-25.
Methocarbamol has actually been delegated to maternity group C by the FDA. Pet research studies have not been stated. There are no regulated data in human maternity. Methocarbamol is not suggested for usage in women which are or may conceive (specifically early pregnancy) unless in the judgment of the medical professional, the possible perks exceed the prospective threats.